YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Mallinckrodt to combine with Endo in $6.7B deal

Posted online

Drugmakers Mallinckrodt and Endo are set to combine.

The companies reached a cash-and-stock deal valued at $6.7 billion. Endo shareholders will receive $80 million in cash and own nearly 50% of the combined company. Mallinckrodt shareholders would own the remainder.

Mallinckrodt CEO Siggi Olafsson will lead the combined operation.

Read more from The Associated Press.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences